| Back 2 Life Medical Inc | |
|
2016 S Eagle Rd, Meridian, ID 83642-6707 | |
| (208) 887-6810 | |
| (208) 887-6797 |
| Full Name | Back 2 Life Medical Inc |
|---|---|
| Type | Facility |
| Speciality | Nurse Practitioner |
| Location | 2016 S Eagle Rd, Meridian, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033562319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CHIA-874 (Idaho) | Secondary |
| 363L00000X | Nurse Practitioner | NP-1639A (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Back 2 Life Medical Inc 2016 S Eagle Rd, Meridian, ID 83642-6707 Ph: (208) 887-6810 | Back 2 Life Medical Inc 2016 S Eagle Rd, Meridian, ID 83642-6707 Ph: (208) 887-6810 |
News Archive
Researchers have discovered a method for more precise identification of individuals who should undergo testing for genetic mutations of the tumor suppressor gene PTEN, which associates with a variety of conditions including several types of cancers. The research has created a diagnostic scoring system that improves on established criteria.
​Student and faculty volunteers from the University of Houston College of Pharmacy (UHCOP) received national recognition this summer for their work to expand essential health care services for Houston's homeless population.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
Colon cancer, Crohn's, and other diseases of the gut could be better treated - or even prevented - thanks to a new link between inflammation and a common cellular process, established by the University of Warwick.
The U.S. Department of Justice has tapped the expertise of a UMass Lowell researcher to create a program to improve workplace health and safety for the country's 500,000 correctional officers and staff, a population data shows are at high risk for on-the-job injury, stress, obesity and premature death.
› Verified 8 days ago